Editorial Board
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Interests: neuro-oncology; brain tumor surgery
Interests: neuro-oncology; brain tumor surgery
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98122 Messina, Italy
Interests: neuroinflammation; neuromodulation; astrocytes; spinal cord injury; brain trauma; cytokines; neurodegenerative disorders; brain tumors
Special Issues, Collections and Topics in MDPI journals
Interests: neuroinflammation; neuromodulation; astrocytes; spinal cord injury; brain trauma; cytokines; neurodegenerative disorders; brain tumors
Special Issues, Collections and Topics in MDPI journals
Department of Neurology, Vickie and Jack Farber, Institute for Neuroscience at Jefferson Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
Interests: primary cns lymphoma; gliomas; brain metastases
Interests: primary cns lymphoma; gliomas; brain metastases
Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK
Interests: pancreatic cancer; pancreatitis; Hsp90
Interests: pancreatic cancer; pancreatitis; Hsp90
Department of Nuclear Medicine, University Hospital, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
Interests: radioiodine; thyroid cancer; PSMA; prostate cancer; Lutetium; PRRT
Interests: radioiodine; thyroid cancer; PSMA; prostate cancer; Lutetium; PRRT
Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: cancer biomarkers; proteomics; cancer surfaceome; immunooncology
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biomarkers; proteomics; cancer surfaceome; immunooncology
Special Issues, Collections and Topics in MDPI journals
Department of Translational Molecular Medicine, Saint John’s Cancer Institute (SJCI), Providence Saint John’s Health Center (SJHC), Santa Monica, CA 90404, USA
Interests: Circulating Tumor Cells (CTC); circulating cell-free DNA/miRNA biomarkers; molecular blood biomarkers; epigenetic; ubiquitin; solid tumors
Interests: Circulating Tumor Cells (CTC); circulating cell-free DNA/miRNA biomarkers; molecular blood biomarkers; epigenetic; ubiquitin; solid tumors
MedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria
Interests: radiotherapy
Interests: radiotherapy
Department of Engineering & IT, Carinthia University of Applied Sciences, 9524 Villach, Austria
Interests: oral cancer; oral squamous cell carcinoma; OSCC; heteroplasmy; mitochondrial DNA; mtDNA; next generation sequencing; NGS; survival analysis; haplogroup
Interests: oral cancer; oral squamous cell carcinoma; OSCC; heteroplasmy; mitochondrial DNA; mtDNA; next generation sequencing; NGS; survival analysis; haplogroup
Department of Gastroenterological Surgery, Osaka Metropolitan University, Osaka, Japan
Interests: surgical oncology; minimally invasive surgery; robotic surgery; prognostic factor; systemic inflammation; nutritional prognostic index
Interests: surgical oncology; minimally invasive surgery; robotic surgery; prognostic factor; systemic inflammation; nutritional prognostic index
1. Department of Digestive Surgery, Nihon University School of Medicine, 30-1, Oyaguchikami-machi, Itabashi-ku, Tokyo 173-8610, Japan
2. Department of General Surgery, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan
Interests: colorectal cancer; hepatocellular carcinoma; colorectal cancer liver metastasis; genome; pathology; drug sensitivity; carcinogenesis; machine learning method; personalized medicine
2. Department of General Surgery, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan
Interests: colorectal cancer; hepatocellular carcinoma; colorectal cancer liver metastasis; genome; pathology; drug sensitivity; carcinogenesis; machine learning method; personalized medicine
Department of Computer Science, Tissue Image Analytics Centre, University of Warwick, Coventry, UK
Interests: pattern recognition; digital pathology; cancer biomarkers; image analytics; applied machine learning
Interests: pattern recognition; digital pathology; cancer biomarkers; image analytics; applied machine learning
1. Royal Melbourne Hospital, Melbourne 3052, Australia
2. Peter MacCallum Cancer Centre, University of Melbourne, Parkville 3010, Australia
Interests: lymphoproliferative disorders; early drug development; clinical trials; targeting apoptosis
Special Issues, Collections and Topics in MDPI journals
2. Peter MacCallum Cancer Centre, University of Melbourne, Parkville 3010, Australia
Interests: lymphoproliferative disorders; early drug development; clinical trials; targeting apoptosis
Special Issues, Collections and Topics in MDPI journals
Department of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ 85724, USA
Interests: oxidative stress; melanoma; skin cancer
Special Issues, Collections and Topics in MDPI journals
Interests: oxidative stress; melanoma; skin cancer
Special Issues, Collections and Topics in MDPI journals
Department of Medical Imaging, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
Interests: nuclear medicine; molecular diagnostics; radiology; imaging; immunology
Interests: nuclear medicine; molecular diagnostics; radiology; imaging; immunology
Department of Radiation Oncology, University of Virginia, 1300 Jefferson Park Avenue, Charlottesville, VA, USA
Interests: genomic instability and human cancer; ubiquitin-dependent regulation of DNA replication; cellular responses to DNA damage; DNA damage repair
Special Issues, Collections and Topics in MDPI journals
Interests: genomic instability and human cancer; ubiquitin-dependent regulation of DNA replication; cellular responses to DNA damage; DNA damage repair
Special Issues, Collections and Topics in MDPI journals
Department of Ophthalmology, Division of Human Genetics, The Ohio State University, Columbus, OH 43210, USA
Interests: cancer genetics; cancer susceptibility; BAP1; ocular tumors; liver tumors
Interests: cancer genetics; cancer susceptibility; BAP1; ocular tumors; liver tumors
1. Division of Molecular and Translational Radiation Oncology, Heidelberg University Hospital (UKHD) Heidelberg Ion-Beam Therapy Center (HIT) Im Neuenheimer Feld 450 and Clinical Cooperation Unit Translational Oncology, 69120 Heidelberg, Germany2. Cancer Consortium (DKTK), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany
Interests: tumor evolution; translational research; radiation oncology; particle therapy; personalized oncology; tumor-stroma-communication; antiangiogenic therapy; tumor resistance
Interests: tumor evolution; translational research; radiation oncology; particle therapy; personalized oncology; tumor-stroma-communication; antiangiogenic therapy; tumor resistance
1. Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, QC H4A 3J1, Canada
2. Cancer Research Program, Research Institute of McGill University Health Center Glen Site, Montreal, QC H4A 3J1, Canada
Interests: glioblastoma; radiation therapy; radioresistance and radiation sensitizers; reactive oxygen species; DNA damage; thioredoxin/glutathione inhibitors; temozolomide chemoresistance; clinical trials; biomarkers
Special Issues, Collections and Topics in MDPI journals
2. Cancer Research Program, Research Institute of McGill University Health Center Glen Site, Montreal, QC H4A 3J1, Canada
Interests: glioblastoma; radiation therapy; radioresistance and radiation sensitizers; reactive oxygen species; DNA damage; thioredoxin/glutathione inhibitors; temozolomide chemoresistance; clinical trials; biomarkers
Special Issues, Collections and Topics in MDPI journals
1. Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2. Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
Interests: liver cancer; HCC; cholangiocarcinoma; gallbaldder cancer; biliary cancer
2. Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
Interests: liver cancer; HCC; cholangiocarcinoma; gallbaldder cancer; biliary cancer
Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22903, USA
Interests: basic and translational brain tumor research
Special Issues, Collections and Topics in MDPI journals
Interests: basic and translational brain tumor research
Special Issues, Collections and Topics in MDPI journals
Division of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, A-1090 Vienna, Austria
Interests: tumor-host interaction; tumor microenvironment; tumor-associated macrophage; signal transduction; tumor angiogenesis; CSF-1; IL-34; tumor invasion and metastasis; preclinical cancer therapeutics
Interests: tumor-host interaction; tumor microenvironment; tumor-associated macrophage; signal transduction; tumor angiogenesis; CSF-1; IL-34; tumor invasion and metastasis; preclinical cancer therapeutics
Hematology, S. Eugenio Hospital, Tor Vergata University, ASL ROma2, 00144 Rome, Italy
Interests: Chronic Myeloid Leukema; Tyrosin kinase inhibitors in hematologic diseases (CML; ALL; mastocytosis; hypereosinophilia); myeloproliferative disorders; myelofibrosis; Hodgkin lymphoma; aggressive non -Hodgkin Lymphomas; pregnancy in hematologic diseases
Interests: Chronic Myeloid Leukema; Tyrosin kinase inhibitors in hematologic diseases (CML; ALL; mastocytosis; hypereosinophilia); myeloproliferative disorders; myelofibrosis; Hodgkin lymphoma; aggressive non -Hodgkin Lymphomas; pregnancy in hematologic diseases
Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA
Interests: hematopathology; lymphoid leukemias and lymphomas; cytogenetics; molecular diagnostics
Special Issues, Collections and Topics in MDPI journals
Interests: hematopathology; lymphoid leukemias and lymphomas; cytogenetics; molecular diagnostics
Special Issues, Collections and Topics in MDPI journals
Dr. Farrukh Afaq
Editorial Board Member
Department of Dermatology, The University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA
Interests: cancer chemoprevention; photocarcinogenesis; melanoma; targeted therapies; psoriasis; biochemical toxicology; cell signaling pathways
Interests: cancer chemoprevention; photocarcinogenesis; melanoma; targeted therapies; psoriasis; biochemical toxicology; cell signaling pathways
Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany
Interests: head & neck cancer with focus on salivary gland and sinonasal tract neoplasms; GI stromal tumors (GIST) with focus on molecular progression pathways, therapy effects and drug resistance; GI & pancreatobiliary cancer with focus on neuroendocrine and poorly differentiated/dedifferentiated neoplasms; soft tissue tumors/sarcoma; undifferentiated malignancies with focus on dedifferentiated melanoma; hereditary tumor syndromes with focus on neurofibromatosis type 1 & hereditary GI & urological cancer syndromes; SWI/SNF-deficient neoplasia with focus on the role of SWI/SNF complex in the initiation, progression and dedifferentiation of neoplasms of different organs
Interests: head & neck cancer with focus on salivary gland and sinonasal tract neoplasms; GI stromal tumors (GIST) with focus on molecular progression pathways, therapy effects and drug resistance; GI & pancreatobiliary cancer with focus on neuroendocrine and poorly differentiated/dedifferentiated neoplasms; soft tissue tumors/sarcoma; undifferentiated malignancies with focus on dedifferentiated melanoma; hereditary tumor syndromes with focus on neurofibromatosis type 1 & hereditary GI & urological cancer syndromes; SWI/SNF-deficient neoplasia with focus on the role of SWI/SNF complex in the initiation, progression and dedifferentiation of neoplasms of different organs
1. Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
2. Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece
Interests: circulating tumor cells; ctDNA; liquid biopsy; biomarkers; lung cancer; breast cancer
2. Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece
Interests: circulating tumor cells; ctDNA; liquid biopsy; biomarkers; lung cancer; breast cancer
Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA
Interests: prostate cancer metastasis
Interests: prostate cancer metastasis
Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy
Interests: p53 family; genes and metabolism; cancer
Interests: p53 family; genes and metabolism; cancer
Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA
Interests: brain metastases; glioblastoma; clinical trial; neuro-oncology; glioma
Interests: brain metastases; glioblastoma; clinical trial; neuro-oncology; glioma
